Role of DZIP1-CBY-FAM92 transition zone complex in the basal body to membrane attachment and ciliary budding.


Journal

Biochemical Society transactions
ISSN: 1470-8752
Titre abrégé: Biochem Soc Trans
Pays: England
ID NLM: 7506897

Informations de publication

Date de publication:
30 06 2020
Historique:
received: 11 03 2020
revised: 20 04 2020
accepted: 07 05 2020
pubmed: 4 6 2020
medline: 20 2 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

Cilia play important signaling or motile functions in various organisms. In Human, cilia dysfunctions are responsible for a wide range of diseases, called ciliopathies. Cilia assembly is a tightly controlled process, which starts with the conversion of the centriole into a basal body, leading to the formation of the ciliary bud that protrudes inside a ciliary vesicle and/or ultimately at the cell surface. Ciliary bud formation is associated with the assembly of the transition zone (TZ), a complex architecture of proteins of the ciliary base which plays critical functions in gating proteins in and out of the ciliary compartment. Many proteins are involved in the assembly of the TZ, which shows structural and functional variations in different cell types or organisms. In this review, we discuss how a particular complex, composed of members of the DZIP1, CBY and FAM92 families of proteins, is required for the initial stages of cilia assembly leading to ciliary bud formation and how their functional hierarchy contributes to TZ assembly. Moreover, we summarize how evidences in Drosophila reveal functional differences of the DZIP1-CBY-FAM92 complex in the different ciliated tissues of this organism. Whereas it is essential for proper TZ assembly in the two types of ciliated tissues, it is involved in stable anchoring of basal bodies to the plasma membrane in male germ cells. Overall, the DZIP1-CBY-FAM92 complex reveals a molecular assembly pathway required for the initial stages of ciliary bud formation and that is conserved from Drosophila to Human.

Identifiants

pubmed: 32491167
pii: 225125
doi: 10.1042/BST20191007
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Antigens, Neoplasm 0
CBY1 protein, human 0
CIBAR1 protein, human 0
Carrier Proteins 0
Cation Transport Proteins 0
Cby protein, Drosophila 0
Cell Cycle Proteins 0
Cep290 protein, human 0
Cytoskeletal Proteins 0
DZIP1 protein, human 0
Drosophila Proteins 0
Microtubule-Associated Proteins 0
Nuclear Proteins 0
Proteins 0
Zip42C.1 protein, Drosophila 0
centrosomal protein 290, Drosophila 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1075

Informations de copyright

© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Auteurs

Jean-André Lapart (JA)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon-1, CNRS UMR-5310, INSERM U-1217, F-69008 Lyon, France.

Amélie Billon (A)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon-1, CNRS UMR-5310, INSERM U-1217, F-69008 Lyon, France.

Jean-Luc Duteyrat (JL)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon-1, CNRS UMR-5310, INSERM U-1217, F-69008 Lyon, France.

Joëlle Thomas (J)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon-1, CNRS UMR-5310, INSERM U-1217, F-69008 Lyon, France.

Bénédicte Durand (B)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon-1, CNRS UMR-5310, INSERM U-1217, F-69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH